Kevin D. Weber - 12 Jul 2024 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Kevin D. Weber
Issuer symbol
BFRI
Transactions as of
12 Jul 2024
Transactions value $
$0
Form type
4
Filing time
16 Jul 2024, 19:52:14 UTC
Previous filing
06 Jun 2022
Next filing
16 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award $0 +20K +1818.18% $0.00 21.1K 12 Jul 2024 Common Stock 20K $1.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments beginning on August 12, 2024.

Remarks:

All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.